RAX, the PKR activator, sensitizes cells to inflammatory cytokines, serum withdrawal, chemotherapy, and viral infection
Richard L. Bennett(University of Florida Health), W. Stratford May(University of Florida Health)
Cited by 79
Related Papers
PKR negatively regulates leukemia progression in association with PP2A activation, Bcl-2 inhibition and increased apoptosis
|Blood Cancer Journal|2013|27
Increased Expression of the dsRNA-Activated Protein Kinase PKR in Breast Cancer Promotes Sensitivity to Doxorubicin
|PLoS ONE|2012|17
A Novel Role for RAX, the Cellular Activator of PKR, in Synergistically Stimulating SV40 Large T Antigen-dependent Gene Expression
|Journal of Biological Chemistry|2003|6